Background illustration for clinical trials search

Paid Clinical Trials Ohio

Discover 3,089 paid clinical trials in Ohio. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Pro-2-Cool Pivotal Trial II

for
Concussion, Mild
Location: Akron OH
Sponsor: TecTraum Inc.

Sex: All

Age: 13 - 21

Code: NCT06929923

Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

for
Astrocytoma, IDH-Mutant, Grade 2,
Location: New Haven CT, Trumbull CT, Mineola NY, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06860594

Phase 1, Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

for
Chronic Myelogenous Leukemia - Chronic Phase
Location: East Setauket NY, Stamford CT, Baltimore MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07091019

Recruiting

Office, Home, and Ambulatory Blood Pressure

for
Elevated Blood Pressure
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 6 - 19

Code: NCT05297708

Recruiting

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

for
Brain Metastases
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07248228

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Boston MA, North Massapequa NY, Richmond Hill NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase 2, Recruiting

Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials

for
Cancer
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07541365

Recruiting

Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma

for
Neuroblastoma
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 1 - 39

Code: NCT07635056

Phase 2, Recruiting

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

for
Liver Transplant
Location: New York NY, Washington D.C. DC, Pittsburgh PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 13

Code: NCT07549503

Phase 2, Recruiting

A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma

for
Metastatic Pancreatic Ductal Adenocarcinoma, PDAC
Location: New Haven CT, Philadelphia PA, Fairfax VA, Cleveland OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07490301

Phase 2, Phase 3, Recruiting

Sleep and Adolescent Vaccine Immunogenicity Pilot/Observational Study

for
Vaccination
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 11 - 12

Code: NCT07636525

Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: London, Kentville, New York NY, Montreal, Richmond VA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577856

Phase 3, Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: London, Halifax, Kentville, New York NY, Montreal,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577843

Phase 3, Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

for
Narcolepsy Type 1, Narcolepsy Type 2
Location: Miami FL, Miami Lakes FL, Orlando FL, Huntersville NC,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 70

Code: NCT07598708

Phase 2, Phase 3, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Shirley NY, Stony Brook NY, Danbury CT, Mineola NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase 3, Recruiting

Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population

for
CRC Screening, Microbiome
Location: Carmel NY, New York NY, Lynchburg VA, Orlando FL,
Sponsor: Jubaan Ltd.

Sex: All

Age: 45 - 70+

Code: NCT07623902

Recruiting

MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

for
Pancreatic Adenocarcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07619391

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: Scarborough ME, Worcester MA, New York NY, Camden NJ,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07059845

Phase 2, Recruiting

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

for
Non-segmental Vitiligo
Location: Hollywood FL, Mayfield Heights OH, Lorain OH,
Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.

Sex: All

Age: 18 - 65

Code: NCT07223229

Phase 2, Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for
Astrocytoma, IDH-Mutant, Grade 3
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 12+

Code: NCT07215910

Phase 3, Recruiting

Popular cities in Ohio

With a robust healthcare network, renowned medical research centers, and innovative treatments, Ohio is a leading destination for a wide range of clinical trials. Institutions such as the Cleveland Clinic, Ohio State University Wexner Medical Center, University Hospitals Cleveland Medical Center, and Nationwide Children’s Hospital are at the forefront of these studies.

Why choose Ohio for clinical trials?

Ohio offers distinct advantages in the clinical research landscape. The state's diverse population provides a wide range of participants, enhancing the accuracy and relevance of research outcomes. Ohio is also recognized for its strong research environment, with a focus on medical innovation and pioneering studies in various fields.

By choosing to participate in a clinical trial in Ohio, participants contribute to vital medical research while benefiting from a well-established clinical trial infrastructure supported by top-tier healthcare institutions. This ensures they receive cutting-edge care and support throughout the process.

Common conditions studied in Ohio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Ohio